131 related articles for article (PubMed ID: 11327663)
1. Activity of amphotericin B in lipid emulsion in the initial treatment of canine leishmaniasis.
Lamothe J
J Small Anim Pract; 2001 Apr; 42(4):170-5. PubMed ID: 11327663
[TBL] [Abstract][Full Text] [Related]
2. Initial and long-term efficacy of a lipid emulsion of amphotericin B desoxycholate in the management of canine leishmaniasis.
Cortadellas O
J Vet Intern Med; 2003; 17(6):808-12. PubMed ID: 14658716
[TBL] [Abstract][Full Text] [Related]
3. Amphotericin B--fat emulsion in treatment of visceral leishmaniasis--a cost effective substitute for liposomal amphotericin B.
Singh GP; Saxena RK; Priyadarshy V
J Indian Med Assoc; 2010 Jan; 108(1):27-8. PubMed ID: 20839576
[TBL] [Abstract][Full Text] [Related]
4. Safety of a pre-formulated amphotericin B lipid emulsion for the treatment of Indian Kala-azar.
Sundar S; Chakravarty J; Agarwal D; Shah A; Agrawal N; Rai M
Trop Med Int Health; 2008 Sep; 13(9):1208-12. PubMed ID: 18664241
[TBL] [Abstract][Full Text] [Related]
5. Activity of liposomal amphotericin B (AmBisome) in dogs naturally infected with Leishmania infantum.
Oliva G; Gradoni L; Ciaramella P; De Luna R; Cortese L; Orsini S; Davidson RN; Persechino A
J Antimicrob Chemother; 1995 Dec; 36(6):1013-9. PubMed ID: 8821600
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of visceral leishmaniasis with high-dose amphotericin B diluted in fat emulsion: a case report.
Herbrecht R; Sosa C; Himy R; Villard O
Trans R Soc Trop Med Hyg; 1996; 90(3):322-3. PubMed ID: 8758094
[No Abstract] [Full Text] [Related]
7. The diagnosis and management of a case of leishmaniosis in a dog imported to Australia.
Best MP; Ash A; Bergfeld J; Barrett J
Vet Parasitol; 2014 May; 202(3-4):292-5. PubMed ID: 24768315
[TBL] [Abstract][Full Text] [Related]
8. Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis.
Sundar S; Gupta LB; Rastogi V; Agrawal G; Murray HW
Trans R Soc Trop Med Hyg; 2000; 94(2):200-4. PubMed ID: 10897369
[TBL] [Abstract][Full Text] [Related]
9. Old world Leishmania infantum cutaneous leishmaniasis unresponsive to liposomal amphotericin B treated with topical imiquimod.
Hervás JA; Martín-Santiago A; Hervás D; Rojo E; Mena A; Rocamora V; Dueñas J
Pediatr Infect Dis J; 2012 Jan; 31(1):97-100. PubMed ID: 21829140
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of childhood cutaneous leishmaniasis with liposomal amphotericin B: report of two cases.
del Rosal T; Artigao FB; Miguel MJ; de Lucas R; del Castillo F
J Trop Pediatr; 2010 Apr; 56(2):122-4. PubMed ID: 19656844
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL).
Musa AM; Khalil EA; Mahgoub FA; Hamad S; Elkadaru AM; El Hassan AM
Ann Trop Med Parasitol; 2005 Sep; 99(6):563-9. PubMed ID: 16156969
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases.
Thakur CP; Singh RK; Hassan SM; Kumar R; Narain S; Kumar A
Trans R Soc Trop Med Hyg; 1999; 93(3):319-23. PubMed ID: 10492770
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial.
Sundar S; Agrawal G; Rai M; Makharia MK; Murray HW
BMJ; 2001 Aug; 323(7310):419-22. PubMed ID: 11520836
[TBL] [Abstract][Full Text] [Related]
14. Amphotericin B infused in 20% lipid emulsion.
Ryan KA
J Intraven Nurs; 1996; 19(3):123-5. PubMed ID: 8788829
[TBL] [Abstract][Full Text] [Related]
15. Treatment of mucosal leishmaniasis with amphotericin B lipid complex (ABLC).
Tuon FF; Santos CR; Cieslinski J; Souza RM; Imamura R; Amato VS
Rev Inst Med Trop Sao Paulo; 2018 Nov; 60():e71. PubMed ID: 30427406
[No Abstract] [Full Text] [Related]
16. Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil.
Dos Santos Nogueira F; Avino VC; Galvis-Ovallos F; Pereira-Chioccola VL; Moreira MAB; Romariz APPL; Molla LM; Menz I
Parasit Vectors; 2019 Feb; 12(1):79. PubMed ID: 30736866
[TBL] [Abstract][Full Text] [Related]
17. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L
Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751
[TBL] [Abstract][Full Text] [Related]
18. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.
Sundar S; Sinha PK; Rai M; Verma DK; Nawin K; Alam S; Chakravarty J; Vaillant M; Verma N; Pandey K; Kumari P; Lal CS; Arora R; Sharma B; Ellis S; Strub-Wourgaft N; Balasegaram M; Olliaro P; Das P; Modabber F
Lancet; 2011 Feb; 377(9764):477-86. PubMed ID: 21255828
[TBL] [Abstract][Full Text] [Related]
19. Acute renal failure due to visceral leishmaniasis by Leishmania infantum successfully treated with a single high dose of liposomal amphotericin B.
Beltrame A; Arzese A; Camporese A; Rorato G; Crapis M; Tarabini-Castellani G; Boscutti G; Pizzolitto S; Calianno G; Matteelli A; Di Muccio T; Gramiccia M; Viale P
J Travel Med; 2008; 15(5):358-60. PubMed ID: 19006511
[TBL] [Abstract][Full Text] [Related]
20. Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases).
Denerolle P; Bourdoiseau G
J Vet Intern Med; 1999; 13(5):413-5. PubMed ID: 10499722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
